September 24, 2020
The Pharmaceuticals and Medical Devices Agency (PMDA) will continue remote GCP on-site inspections and document-based conformity inspections, which have been conducted since the middle of May due to the COVID-19 pandemic, until the end of March 2021. The PMDA introduced...read more